| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 30-Dec-08 | 23-Sep-08 | | Total Revenue | 330,794 | 320,709 | 357,812 | 315,194 | | Cost of Revenue | 262,483 | 254,763 | 450,035 | 81,428 | | | Gross Profit | 68,311 | 65,946 | (92,223) | 233,766 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 18,445 | 20,401 | (152,448) | 193,384 | | Non Recurring | 405 | 340 | 500 | 868 | | Others | 16,579 | 16,419 | 18,057 | 16,794 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,882 | 28,786 | 41,668 | 22,720 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (160) | 318 | (77) | (459) | | Earnings Before Interest And Taxes | 32,722 | 29,104 | 41,098 | 21,245 | | Interest Expense | 209 | 166 | 208 | 225 | | Income Before Tax | 32,513 | 28,938 | 40,890 | 21,020 | | Income Tax Expense | 12,278 | 10,911 | 15,341 | 8,156 | | Minority Interest |
-
|
-
| (493) | (139) | | | | Net Income From Continuing Ops | 20,235 | 18,027 | 25,549 | 13,741 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,235 | 18,027 | 25,549 | 13,741 | | Preferred Stock And Other Adjustments | (206) | (595) |
-
|
-
| | | Net Income Applicable To Common Shares | $20,029 | $17,432 | $25,549 | $13,741 |
|
0.16% Nasdaq 0.00%
Income Statement
